Michael P. Douglas

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

Steven M. Teutsch, Linda Bradley, Glenn E. Palomaki et al. · Genetics in Medicine · 2009 · 674 citations · Full text

Life Sciences, Genetics, Preventive Medicine +14

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Kathryn A. Phillips, Patricia A. Deverka, Gillian W. Hooker et al. · Health Affairs · 2018 · 229 citations

Life Sciences, Genetics, Molecular Genetics +11

Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates

Mark F. Schinsky, Roger E. Morey, Arnold G. Steigerwalt et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2004 · 128 citations

Life Sciences, Infectious Diseases, Microbiology +17

DNA damage caused by common cytological fixatives

Michael P. Douglas, Scott O. Rogers · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 1998 · 118 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +11

The economic value of personalized medicine tests: what we know and what we need to know

Kathryn A. Phillips, Julie Sakowski, Julia R. Trosman et al. · Genetics in Medicine · 2013 · 117 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +13